Results 271 to 280 of about 681,261 (380)

Combined effect of TA-993 and tissue plasminogen activator (t-PA) on the disaggregation of thrombin-induced platelet-rich clots in human platelet-rich plasma (PRP)

, 1995
Tomihiro Ikeo, Makoto Katoh, Akio Odawara, Sakae Murata   +3 more
openalex   +1 more source

Combination of Tissue-Plasminogen Activator With Erythropoietin Induces Blood–Brain Barrier Permeability, Extracellular Matrix Disaggregation, and DNA Fragmentation After Focal Cerebral Ischemia in Mice

Stroke, 2010
A. Zechariah, Ayman ElAli, D. Hermann
semanticscholar   +1 more source

Intravenous Thrombolysis in Patients Taking Direct Oral Anticoagulation Treatment Before Stroke Onset: Results from the Safe Implementations of Treatments in Stroke International Stroke Registry

Annals of Neurology, Volume 97, Issue 6, Page 1205-1214, June 2025.
Objectives Intravenous thrombolysis (IVT) is contraindicated for acute ischemic stroke (AIS) patients taking direct oral anticoagulants (DOACs) within 48 hours before index stroke. Limited data exist on off‐label use of IVT for these patients. We compared the safety and outcomes of IVT in AIS patients with DOAC treatment and patients with no OAC before
Marius Matusevicius, Malin Säflund, Maurizio Balestrino, Manuel Cappellari, Delfina Ferrandi, Abdoreza Ghoreishi, André Peeters, Viiu‐Marika Rand, Manuela De Michele, Aleksandras Vilionskis, Andrea Zini, Niaz Ahmed   +11 more
wiley   +1 more source

Tissue Plasminogen Activator [PDF]

New England Journal of Medicine, 1989
openaire   +2 more sources

The Relationship Between Body Mass Index and Recurrence Risk of Stroke: A Systematic Review and Dose–Response Meta‑Analysis

Brain and Behavior, Volume 15, Issue 6, June 2025.
The obesity paradox can be extended to stroke recurrence. A 2% reduction in recurrence risk of stroke per 1‐unit increase in BMI. ABSTRACT Objective To explore the relationship between body mass index (BMI) and the recurrence risk of stroke. Methods We searched databases, including the Web of Science, Cochrane Library, Embase, PubMed, Chinese ...
Qiuxia Qian, Yuting Zhao, Xin Fan, Jialu Li, Jianxun Cao, Mengyu Yang, Longchun Hua, Xingxia Zhang, Ailing Yang, Fengwa Zhang, Yuxia Ma   +10 more
wiley   +1 more source

Dermal cellular senescence and EndMT in patients with systemic sclerosis undergoing cyclophosphamide or aHSCT treatment. [PDF]

Rheumatology (Oxford)
Chiu YH, van Dijk M, Goldschmeding R, van Laar JM, de Vries-Bouwstra JK, Spierings J.   +5 more
europepmc   +1 more source

Mural thrombus of the aorta in association with homozygous plasminogen activator inhibitor type 1 (PAI-1)-675(4G) and heterozygous GP Ia 807C/T genotypes

, 2002
Guido Beldi, A Bissat, Thomas Eugster, Lorenz Gürke, P. Stierli, Andreas Huber   +5 more
openalex   +1 more source

Massive Acute Thrombosis of a Mechanical Mitral Valve in a Young Patient on Acenocoumarin: A Case Report Comparing Surgical and Thrombolytic Approaches

Clinical Case Reports, Volume 13, Issue 6, June 2025.
ABSTRACT Obstructive mechanical mitral valve thrombosis is a life‐threatening emergency requiring urgent intervention. Surgery is often first‐line; thrombolysis may be considered in high‐risk cases. A multidisciplinary approach is essential to balance thromboembolic and bleeding risks, emphasizing early recognition, optimized anticoagulation, and ...
Said Khallikane, Bassam Bencharfa, Noureddine Atmani, Abdessamad Abdou, Ayoub Belhadj, Younes Aissaoui   +5 more
wiley   +1 more source

Plasma SuPAR and therapeutic response to erenumab in migraine: a REFORM study. [PDF]

J Headache Pain
Karlsson WK, Christensen RH, Al-Khazali HM, Kallemose T, Jawad BN, Andersen O, Ashina M, Ashina H.   +7 more
europepmc   +1 more source

Contemporary Perspectives on Chronic Renal Disorders

Chronic Diseases and Translational Medicine, Volume 11, Issue 2, Page 89-104, June 2025.
ABSTRACT The prevalence of renal diseases and its associated burden on healthcare have tremendously risen in the past few years. From simple markers assessing kidney function, current renal research delves into understanding the diseases at the cellular and molecular levels and not just at treating, but at improving quality of life, arresting ...
Deenadhayalan Ashok, Poornima Ajay Manjrekar, Bhushan C. Shetty, Sujina S. S, Rukmini Mysore Srikantiah, Sowndarya Kollampare   +5 more
wiley   +1 more source